Printer Friendly VersionEmail A FriendAdd ThisIncrease Text SizeDecrease Text Size

Central serous choroidopathy



Central serous choroidopathy is a disease that causes fluid to build up under the retina, the part of the eye that sends sight information to the brain. The fluid leaks from the blood vessel layer under the retina. This area is called the choroid.

Alternative Names

Central serous retinopathy


The cause of this condition is unknown. Most patients are young men with aggressive, "type A" personalities, but anyone can be affected.

Stress appears to be a risk factor. The condition can also occur as a complication of steroid drug use.

  • Dim and blurred blind spot in the center of vision
  • Distortion of straight lines with the affected eye
  • Objects appearing smaller or farther away with the affected eye
Signs and tests

Your health care provider can usually diagnose central serous choroidopathy by dilating the eye and performing an eye exam. Fluorescein angiography confirms the diagnosis.

Support Groups

Expectations (prognosis)

Most patients recover good vision without treatment. The disease returns in about half of all patients, and has a similarly good outlook. Rarely, patients develop permanent scars that damage their central vision.

Calling your health care provider

Call your health care provider if visual symptoms worsen.


A small number of patients will have complications of laser treatment that impair central vision. That is why most patients will be allowed to recover without treatment.


Most cases clear up without treatment in 1 or 2 months. Patients with more severe leakage and more severe visual loss, or those in whom the disease lasts longer, may be helped by laser treatment to seal the leak.

Patients who are using steroid drugs (for example, to treat autoimmune diseases) should discontinue their use if possible. Any change in steroid drug use in these conditions must be under the supervision of a physician.


There is no known prevention. Although there is a clear association with stress, there is no evidence that tranquilizer drugs have any benefit in preventing or treating central serous choroidopathy.

Read More

Review Date: 8/22/2008
Reviewed By: Paul B. Griggs, MD, Department of Ophthalmology, Virginia Mason Medical Center, Seattle, WA. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission ( URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2009 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

Home Page
Why Choose Us
Website Terms of Use

Visitor & Patient Info
Patient Portal
We Speak Your Language
Patient Privacy
Contact Us

Find a Physician
Medical Services
Maimonides In the News
Directions & Parking

Medical Education
Career Opportunities
Nurses & Physicians
Staff Intranet Access
Maimonides Medical Center    |    4802 Tenth Avenue    |    Brooklyn, NY 11219    |    718.283.6000    |